To investigate whether Gdf10 affects MASH progression, we administered control AAV or Gdf10-expressing AAV via tail vein injection to C57BL/6J mice in diet-induced MASH model (Fig. 2A). Here, GDF10 is linked to metabolic dysfunction-associated steatohepatitis.